 REHOVOT, Israel, Nov. 04, 2020 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ TASE: KMDA, plasma-derived biopharmaceutical company, today announced that it will release financial results for the third quarter ended September 30, 2020, prior to the open of the U.S. financial markets on Wednesday, November 11, 2020. 